Updated 03/29/2022

CHC IS HERE FOR YOU!

Compassion Health Care, Inc. wants you to know that we are here for you.

We had to change our role to help our community in the Coronavirus (COVID-19) crisis, but we are still serving our patients with excellent patient-centered healthcare, including primary care, urgent care, behavioral health, psychiatry, and specialty care, which now includes Palliative Care.

PLEASE REMEMBER:

  • Only one (1) mask is required now inside each of our medical centers, even if you have been vaccinated.
  • Patients must call to make an appointment for their primary care visit, just like we’ve always done.
  • Urgent Care is open without any appointment necessary.
  • You no longer have to call from the parking lot at either our JAHC or CFMC locations prior to coming in.
  • Our waiting room is open in Primary Care for our patients with safety precautions still in place.
  • NOTE: As of 4/1/2022, CHC medical center sites will no longer offer community-based COVID-19 testing. Our Mobile Unit will continue to offer COVID-19 testing to anyone who wants it; however, we will only offer COVID specimen collection from CFMC and JAHC based on a provider order that would be part of an office visit in the same way that we offer any other lab test. We will provide at-home test kits to anyone who wants them for them to self administer their own tests.

CORONAVIRUS (COVID-19): WHAT YOU NEED TO KNOW

On March 29,2022 the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.
The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for severe disease, hospitalization and death.
The agency amended the emergency use authorization as follows:
• A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
• A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise.
• A second booster dose of the Moderna COVID-19 Vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise.
This action applies only to the Pfizer-BioNTech and Moderna COVID-19 vaccines and the authorization of a single booster dose for other age groups with these vaccines remains unchanged. The agency will continue to evaluate data and information as it becomes available when considering the potential use of a second booster dose in other age groups.
A summary of safety surveillance data provided to the FDA by the Ministry of Health of Israel on the administration of approximately 700,000 fourth (second booster) doses of the Pfizer-BioNTech COVID-19 Vaccine given at least 4 months after the third dose in adults 18 years of age and older (approximately 600,000 of whom were 60 years of age or older) revealed no new safety concerns.
The safety of Moderna COVID-19 Vaccine, when administered as a second booster dose, is informed by experience with the Pfizer-BioNTech COVID-19 Vaccine and safety information reported from an independently conducted study in which the Moderna COVID-19 Vaccine was administered as a second booster dose to 120 participants 18 years of age and older who had received a two-dose primary series and a first booster dose of Pfizer-BioNTech COVID-19 Vaccine at least 4 months prior. No new safety concerns were reported during up to three weeks of follow up after the second booster dose.

References
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-second-booster-dose-two-covid-19-vaccines-older-and

There are simple things you can do to keep yourself and others healthy:

  • Wash your hands often with soap and water for at least 20 seconds, especially after blowing your nose, coughing or sneezing, going to the bathroom, and before eating or preparing food.
  • Avoid touching your eyes, nose, and mouth with unwashed hands.
  • GET VACCINATED!
    • COVID-19 vaccines are safe and effective
    • Pfizer-BioNTech vaccine is now the first FDA approved COVID-19 vaccine (read more)
    • Everyone 12 years of age and older are now eligible to get a COVID-19 vaccination.
    • Call our COVID-19 vaccine call center at 336-694-1181
      • Call Center Hours:
        • Monday & Thursday, 8:00 am to 5:00 pm and Friday, 8:00 am to Noon.
    • Vaccines will be scheduled at Caswell Family Medical Center on Tuesdays from 8:30 AM to 4:00 PM.
    • Vaccines will be scheduled at James Austin Health Center on Wednesdays from 1:00 PM to 4:00 PM.

There is a LOT of misinformation out there about Coronavirus. For accurate information, please visit:

COVID-19 IMPORTANT RESOURCES IN CASWELL COUNTY

  • Caswell Family Medical Center – (336) 694-9331
  • Caswell County Health Department – (336) 694-4129
  • NC 211 – 24/7 access for organizations in our local community to assist with food, shelter, energy assistance, housing, parenting resources, health care, employment, substance abuse treatment as well as services specific to older adults and those with disabilities. Dial 2-1-1 or 888-892-1162.
  • Text COVIDNC to 898211 to receive general information and updates about COVID-19 in NC

Updated Insurance Provider & Coverage Information

BCBSNC will be posting updates on COVID-19 HERE

Cigna customers will have access to coronavirus (COVID-19) testing, as prescribed by health practitioners, and the company will waive all co-pays or cost-shares to help fight the rapid spread of the virus in the U.S. and for its globally mobile customers.

Access the Cigna announcement HERE

Bright Health members whose care providers have ordered testing will have COVID-19 diagnostic tests covered as preventive care at no cost to the member. Learn more HERE

Any medically necessary treatment related to COVID-19 would be considered a covered benefit, consistent with benefit coverage provisions of your policy for treatment of an illness. General plan cost-sharing requirements will apply for medically necessary treatment related services. Learn more HERE

For the latest information on Social Security & Coronavirus, including frequently asked questions like “will SSA provide in-person services during the COVID-19 pandemic”, please visit HERE

The NC Department of Insurance (NCDOI) will be updating information about SHIIP HERE.

If you currently have insurance coverage through the marketplace, the rules in your health plan for treatment for the COVID-19 emergency remain the same as any other viral infection, according to HealthCare.Gov.

Visit healthcare.gov for more information on coverage and for questions regarding special enrollment periods.